|
1）Friedenstein AJ, Deriglasova UF, Kulagina NN. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974; 10: 83-92
|
|
|
|
|
2）Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109: 235-42
|
|
|
|
|
3）Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004; 103: 1669-75
|
|
|
|
|
|
4）Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005; 23; 3-9
|
|
|
|
|
|
5）Battula VL, Treml S, Abele H, et al. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation. 2008; 76: 326-36
|
|
|
|
|
|
6）Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000; 97: 13625-30
|
|
|
|
|
|
7）Shi S, Gronthos S. Pericascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 2003; 18: 696-704
|
|
|
|
|
|
8）Orbay H, Tobita M, Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int. 2012 Article ID 461718 9 pages, 2012
|
|
|
|
|
|
9）Liu TM, Martina M, Hutmacher DW, et al. Idntification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal linageses. Stem Cells. 2007; 25; 750-60
|
|
|
|
|
|
10）Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991; 78: 55-62
|
|
|
|
|
|
11）Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002; 30: 783-91
|
|
|
|
|
|
12）Gronthos S, Zannettino ACW, Hay SJ, et al. Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003; 116: 1827-35
|
|
|
|
|
|
13）Boiret N, Papatel C, Veyrat-Masson R, et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol. 2005; 33: 219-25
|
|
|
|
|
|
14）Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7
|
|
|
|
|
|
15）Aslan H, Zilberman Y, Kandel L, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells. 2006; 24: 1728-37
|
|
|
|
|
|
16）Gang EJ, Bosnakovski D, Figueiredo CA, et al. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007; 109: 1743-51
|
|
|
|
|
|
17）Battula VL, Treml S, Bareiss PM, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009; 94: 173-84
|
|
|
|
|
|
18）Buhring HJ, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci. 2007; 1106: 262-71
|
|
|
|
|
|
19）Tormin A, Li O, Brune JC, et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood. 2011; 117: 5067-77
|
|
|
|
|
|
20）Mabuchi Y, Morikawa S, Harada S, et al. LNGFR+THY-1+VAM-1hi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Reports. 2013; 1: 152-65
|
|
|
|
|
|
21）Matsuzaki Y, Kinjo K, Mulligan RC, et al. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity. 2004; 20: 87-93
|
|
|
|
|
|
22）Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med. 2009; 206: 2483-96
|
|
|
|
|
|
23）Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010; 66: 829-34
|
|
|
|
|
|
24）Zhou B, Yue R, Murphy MM, et al. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014; 15: 154-68
|
|
|
|
|
|
25）Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Med. 2009; 15: 42-9
|
|
|
|
|
|
26）François M, Romieu-Mourez R, Li M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2010; 20: 187-95
|
|
|
|
|
|
27）Le RH, Pulin AA, Seo MJ, et al. Intravenous hM SCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009; 5: 54-63
|
|
|
|
|
|
28）Roddy GW, Oh JY, Lee RH, et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells. 2011; 29: 1572-9
|
|
|
|
|
|
29）Oh JY, Roddy GW, Choi H, et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A. 2010; 107: 16875-80
|
|
|
|
|
|
30）Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther. 2010; 18: 1857-64
|
|
|
|
|